Revisiting the relationship between essential tremor and Parkinson's disease

Movement Disorders

Volumn 26, Issue 3, 2011, Pages 391-398

  Fekete, R ^a   Jankovic, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebellum; Essential tremor; Lewy bodies; Parkinson's disease; Tremor

Indexed keywords

6 FLUORODOPA; ALCOHOL; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL)TROPANE I 123; CLONAZEPAM; IOFLUPANE I 123; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; NOGO 66 RECEPTOR; PRIMIDONE; PROPRANOLOL; RADIOPHARMACEUTICAL AGENT; TOPIRAMATE; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG MEGADOSE; EPIDEMIOLOGICAL DATA; ESSENTIAL TREMOR; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MEDLINE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

DIAGNOSTIC IMAGING; ESSENTIAL TREMOR; GENETIC TESTING; HUMANS; PARKINSON DISEASE; PUBMED;

EID: 79953287466     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23512     Document Type: Article

References (74)

1. Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord 2010; 25: 534-541.
2. Moghal S, Rajput AH, D'Arcy C, Rajput R. Prevalence of movement disorders in elderly community residents. Neuroepidemiology 1994; 13: 175-178.
3. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5: 525-535.
4. Koller WC, Busenbark K, Miner K. The relationship of essential tremor to other movement disorders: report on 678 patients. Essential Tremor Study Group. Ann Neurol 1994; 35: 717-723.
5. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991; 41: 234-238.
6. Geraghty JJ, Jankovic J, Zetusky WJ. Association between essential tremor and Parkinson's disease. Ann Neurol 1985; 17: 329-333.
7. Benito-Leon J, Louis ED, Bermejo-Pareja F. Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. J Neurol Neurosurg Psychiatry 2009; 80: 423-425.
8. Raethjen J, Deuschl G. Tremor. Curr Opin Neurol 2009; 22: 400-405.
9. Jain S, Lo SE, Louis ED. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol 2006; 63: 1100-1104.
10. Chaudhuri KR, Buxton-Thomas M, Dhawan V, Peng R, Meilak C, Brooks DJ. Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry 2005; 76: 115-117.
11. Jimenez-Jimenez FJ, Rubio L, Alonso-Navarro H, et al. Impairment of rapid repetitive finger movements and visual reaction time in patients with essential tremor. Eur J Neurol. 2010; 17: 152-159.
12. Montgomery EBJr, Baker KB, Lyons K, Koller WC. Motor initiation and execution in essential tremor and Parkinson's disease. Mov Disord 2000; 15: 511-515.
13. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 646-650.
14. Fekete R, Davidson A, Jankovic, J. Relationship of essential tremor to Parkinson disease compared to progressive supranuclear palsy and corticobasal degeneration. Ann Neurol 2010; 68 (suppl 14): S19-S20.
15. Louis ED, Frucht SJ. Prevalence of essential tremor in patients with Parkinson's disease vs. Parkinson-plus syndromes. Mov Disord 2007; 22: 1402-1407.
16. Mostile G, Giuffrida JP, Adam OR, Davidson A, Jankovic J. Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor. Mov Disord 2010; 25: 1938-1943.
17. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 67-76.
18. Louis ED, Ford B, Frucht S. Factors associated with increased risk of head tremor in essential tremor: a community-based study in northern Manhattan. Mov Dis 2003; 18: 432-436
19. Gan J, Xie-Brustolin J, Gervais-Bernard H, Vallet AE, Broussole E, Thobois S. Possible Parkinson's disease revealed by a pure head resting tremor. J Neurol Sci 2009; 279: 121-123.
20. Jankovic J. Essential tremor: A heterogeneous disorder. Mov Dis 2002; 17: 638-644
21. Sulica L, Louis ED. Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope 2010; 120: 516-28.
22. Lorenz D, Papengut F, Frederiksen H, et al. Evaluation of a screening instrument for essential tremor. Mov Disord 2008; 23: 1006-1012.
23. Schwingenschuh P, Ruge D, Edwards M, Terranova C, et al. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study. Mov Disord 2010; 25( 5): 560-569.
24. Cohen O, Pullman S, Jurewicz E, Watner D, Louis ED. Rest tremor in patients with essential tremor: prevalence, clinical correlates, and electrophysiologic characteristics. Arch Neurol 2003; 60: 405-410.
25. Rajput AH, Rozdilsky B, Ang L, Rajput A. Significance of parkinsonian manifestations in essential tremor. Can J Neurol Sci 1993; 20: 114-117.
26. Djaldetti R, Nageris BI, Lorberboym M, Treves TA, Melamed E, Yaniv E. [123I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. J Neural Transm 2008; 115: 469-472.
27. Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992; 42: 1554-1560.
28. Tan EK, Lee SS, Fook-Chong S, Lum SY. Evidence of increased odds of essential tremor in Parkinson's disease. Mov Disord 2008; 23: 993-997.
29. Hedera P, Fang JY, Phibbs F, Cooper MK, Charles PD, Davis TL. Positive family history of essential tremor influences the motor phenotype of Parkinson's disease. Mov Disord 2009; 24: 2285-2288.
30. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: A base-line analysis of the DATATOP cohort. Neurology 1990; 41: 1529-1534.
31. 123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor dominant vs. akinetic-rigid onset. Neuroreport 2007; 18: 1499-1502.
32. Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 2001; 57: 1389-1391.
33. Jankovic J, Beach J, Schwartz K, Contant C. Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects. Neurology 1995; 45: 645-648.
34. Spanaki C, Plaitakis A. Essential tremor in Parkinson's disease kindreds from a population of similar genetic background. Mov Disord 2009; 24: 1662-1668.
35. Minen MT, Louis ED. Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients. Mov Disord 2008; 23: 1602-1605.
36. Mostile G, Jankovic J. Alcohol in essential tremor and other movement disorders. Mov Disord 2010; 25: 2274-2284.
37. Rocca WA, Bower JH, Ahlskog JE, et al. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord 2007; 22: 1607-1614.
38. Louis ED, Levy G, Mejia-Santana H, et al. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology 2003; 61: 931-936.
39. Deng H, Le W, Davidson AL, Xie W, Jankovic J. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor. Neurosci Lett 2006; 407: 97-100.
40. Skipper L, Shen H, Chua E, et al. Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 2005; 65: 1319-1321.
41. Deng H, Le WD, Hunter CB, Mejia N, Xie WJ, Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations. Arch Neurol 2007; 64: 421-424.
42. Vilariño-Güell C, Ross OA, Wider C, et al. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 2010; 16: 109-111.
43. Inoue H, Lin L, Lee X, et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci U S A 2007; 104: 14430-14435.
44. Stefansson H, Steinberg S, Petursson H, et al. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009; 41: 277-279.
45. Vilariño-Güell C, Wider C, Ross OA, et al. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics Epub April 6 2010.
46. Haubenberger D, Hotzy C, Priker et al. Role of LINGO1 Polymorphisms in Parkinson's Disease. Mov Disord 2009; 24: 2404-2427.
47. Bialecka M, Kurzawski M, Tan EK, Drodzik M. Analysis of LINGO1 (rs9652490) polymorphism in sporadic Parkinson's disease in a Polish population, and a meta-analysis. Neurosci Lett 2010; 472: 53-55
48. Jankovic J, Contant C, Perlmutter J. Essential tremor and PD. Neurology 1993; 43: 1447-1449.
49. Piccini P, Morrish PK, Turjanski N, et al. Dopaminergic function in familial Parkinson's disease: a clinical and 18F-dopa positron emission tomography study. Ann Neurol. 1997; 41: 222-229.
50. Isaias IU, Canesi M, Benti R, et al. Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 2008; 29: 349-353.
51. Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brucke T. [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998; 105: 1213-1228.
52. Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000; 15: 503-510.
53. Ceravolo R, Antonini A, Volterrani D, et al. Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study. Mov Disord 2008; 23: 2049-2054.
54. Lee MS, Kim YD, Im JH, Kim HJ, Rinne JO, Bhatia KP. 123I-IPT brain SPECT study in essential tremor and Parkinson's disease. Neurology 1999; 52: 1422-1426.
55. Schwarz M, Groshar D, Inzelberg R, Hocherman S. Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson's disease. Parkinsonism Relat Disord 2004; 10: 385-389.
56. Antonini A, Isaias IU. Imaging evidence supports a link between essential tremor and Parkinson's disease. Nucl Med Commun 2009; 30: 93-94.
57. Isaias IU, Benti R, Cilia R, et al. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset. Neuroreport 2007; 18: 1499-1502.
58. Isaias IU, Marotta G, Hirano S, et al. Imaging essential tremor. Mov Disord. 2010; 25: 679-686.
59. Arabia G, Novellino F, Morelli M, et al. Mixed tremors with integrity of nigrostriatal system: a clinical and DAT-SPECT follow-up study. Mov Disord 2010; 25: 662-664.
60. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology 2010; 74: 988-994.
61. Berg D, Siefker C, Ruprecht-Dorfler P, Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 2001; 56: 13-17.
62. Budisic M, Trkanjec Z, Bosnjak J, Lovrencic-Huzjan A, Vukovic V, Demarin V. Distinguishing Parkinson's disease and essential tremor with transcranial sonography. Acta Neurol Scand 2009; 119: 17-21.
63. Yahr MD, Orosz D, Purohit DP. Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings. Parkinsonism Relat Disord 2003; 9: 225-231.
64. Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008; 70: 1452-1455.
65. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007; 130: 3297-3307.
66. Louis ED, Faust PL, Vonsattel JP, et al. Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains. Mov Disord 2009; 24: 1600-1605.
67. Shill H, Adler C, Beach T, et al. Striatal Tyrosine Hydroxylase in Autopsied Patients with Essential Tremor. In: Program and abstracts of the American Academy of Neurology 61st Annual Meeting. Seattle: WA; 2009.
68. Louis ED. Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem inquiry. Lancet Neurol 2010: 613-622.
69. Ondo WG, Jankovic J, Connor GS, et al; Topiramate Essential Tremor Study Investigators. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006; 66: 672-677.
70. Hughes AJ, Lees AJ, Stern GM. Apomorphine in the diagnosis and treatment of parkinsonian tremor. Clin Neuropharmacol. 1990; 13: 312-317.
71. Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci 2007; 260: 199-203.
72. Deuschl G, Lucking CH. Tremor and electrically elicited long latency reflexes in early stages of Parkinson's disease. In: Riederer HP, editor. Early diagnosis and preventive therapy of Parkinson's disease. New York: Springer Verlag, 1989: 103-110
73. Young RR, Shahani BT. Pharmacology of tremor. Clin Neuropharm 1979; 4: 139-156.
74. Marjama-Lyons J, Koller W. Tremor-predominant Parkinson's disease. Approaches to treatment. Drugs Aging 2000; 16: 273-278.